Zen Technologies enters its Q1 FY2027 results facing a critical test of its revenue scaling ambitions following a consolidated FY2026 marked by order conversion delays. Investors will be focused on whether the company's operational EBITDA margins have rebounded from the Q4 FY2026 trough and if the large-scale simulator orders previously guided for H1 have begun to materialise.
| Results date | July 25, 2026 |
|---|---|
| Quarter | Q1 FY 2026-2027 |
| Previous quarter revenue | Rs. 178 Cr |
| Previous quarter PAT | Rs. 47.2 Cr |
| Previous quarter EBITDA margin | 28.6% |
| Market cap | Rs. 15,671.27 Cr |
| CMP | Rs. 1,735.65 |
The board meeting is scheduled for July 25, 2026, to consider the standalone and consolidated unaudited financial results for Q1 FY2027.
Management's FY2027 revenue guidance implies a quarterly run-rate of approximately Rs. 375 Cr, placing intense scrutiny on the Q1 revenue figure as the primary indicator of execution momentum. Following the Q4 FY2026 operational EBITDA margin compression to 28.6%, the upcoming print is expected to show a recovery toward the 35% long-term target as one-time costs like year-end employee incentives and warranty provisions subside. While the company launched seven new products in May 2026, including the Integrated Smart Border Suite, these remain pipeline contributors rather than immediate Q1 revenue drivers. The central narrative for the call will be the status of the anticipated Rs. 650 Cr simulator orders, which management previously signaled for H1 FY2027, alongside any updates on the impact of the July 3, 2026, DAC approvals for anti-UAV systems.
Performance vs Guidance Tracking: Tracking the company's progress against its FY2027 revenue and margin targets.
Strategic execution and product updates: Monitoring the commercialisation of recently unveiled defence technologies.
Risks and headwinds to monitor: Factors impacting the pace of order-to-revenue conversion.
The company reported revenue of approximately Rs. 178 Cr in Q4 FY2026. This figure reflects a period of consolidation following delays in finalising regular procurement orders.
The operational EBITDA margin compressed to 28.6% due to five factors, including year-end employee incentives and a structural increase in R&D investments. Management noted that while the R&D spend is a permanent commitment, other factors like warranty provisioning were period-specific.
Management previously guided for large simulator orders worth approximately Rs. 650 Cr to be secured in H1 FY2027. The upcoming earnings call is expected to provide clarity on whether these orders have been finalised.
Management has revised its cumulative revenue target to Rs. 4,000 Cr for FY2027 and FY2028 combined. The company maintains that it has the supply chain capacity to execute this order book, provided the anticipated order inflows materialise.
Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings
Login Now